Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
EU Funding & Tenders Portal HORIZON-MISS-2027-02-CANCER-04 · Horizon Europe (HORIZON)
| Funder | European Commission |
|---|---|
| Status | forthcoming |
| Opens | 10 Feb 2027 |
| Deadline | 16 Sep 2027 — 320 days |
| Action | HORIZON Research and Innovation Actions |
| Official page | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunit… |
| Last checked | 2026-10-31 06:01:29+00:00 |
The scope text was read and no clause in it rules a field out. That is not a guarantee — read the call before you commit to it.
You are reading one call. 1,050 are open right now.
A search matches words. It cannot know what your institution works on. Give the name and every open call is ranked against it — this one included.
This call page is free · no account · the report arrives by emailWhat this call is
| Instrument | HORIZON-RIA |
|---|---|
| Stages | single-stage |
| EU contribution | €5.0m to €7.0m per project |
| Projects expected | 3, sharing €10.0m |
From the Commission's own budget table for this call. Confirm against the topic page before you plan around it: these move when a work programme is amended.
Scope
Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: People at risk of cancer, cancer patients and their caregivers/families benefit from access to more effective and cost-effective, national or regional, cancer control programmes across EU Member States and Associated Countries. Researchers, physicians, innovators [1] , SMEs and other professionals from different disciplines and sectors have access to national, regional or local data on healthcare spending (such as expenditures, resource allocations, organisation and type of healthcare interventions, and for which cancer indications, infrastructure, medical prescriptions, drug pricing, drug sales, reimbursement data from health insurers, population-based cancer registries or other cancer-centred registry data, longitudinal epidemiology data) for research and commercial purposes. National or regional healthcare systems, healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to improve equitable health outcomes of cancer patients by addressing direct and indirect costs, delivering value-driven cancer care and tackling organisational challenges of a rapidly-changing, dynamic cancer control [2] landscape. Scope: Proposals should address all of the following: Establish, validate or further refine health-economics research, health systems research, epidemiological or outcomes research methods, models, or modelling to perform (comparative) cost-effectiveness and epidemiological analyses benefiting equitable health outcomes of and added value for people at risk of cancer as well as cancer patients living with and beyond their disease. Take into account socio-economic inequalities, socio-demographic, organisational, innovative or cultural trends, socio-cultural or behavioural change (for example in the case of primary prevention or precision medicine) by involving people at risk of cancer or cancer patients and their caregivers/families through research that stimulates social innovation and supports end-user engagement using participative research models. Calculate cancer-control related healthcare expenditures [3] and its relation to value-driven healthcare benefitting health outcomes of people at risk of cancer as well as cancer patients living with and beyond their disease, taking into account the needs of the target population and the specificities of healthcare provision at local, regional, or national level, duly…
What consortia for this call have looked like
3 projects
have been funded under this line
(HORIZON-MISS-CANCER-04) in Horizon Europe and H2020. This is what they
were made of — not a recommendation, just what the Commission signed.
range 8–16
11 seen across all of them
across those projects
The mix of organisations
Who coordinated them
Coordinating an EU project is a demanding, specific job. These organisations have done it on this topic line before.
This is the shape, not the consortium. It says how many partners these projects had and what kinds of organisation were in them. It does not know whether your idea needs the same mix, who is available, who is already committed elsewhere, or how the work and the budget should be divided. Those are judgement calls on a specific proposal, and no amount of public data answers them.
Building the actual consortium — finding the partners, agreeing the roles, and writing it so it survives an evaluation — is what Scientific Network Management does. Free either way; the radar does not change if you never ask.
Get told when something changes
Most institutions find out about a call with three weeks left. We write when something opens, moves or closes that fits what you work on, with the deadline, the fit and the funder's own exclusion clauses quoted. Nothing in a quiet week. Free, and one click to leave.
Starting from the programme you are reading: Horizon Europe (HORIZON) — change it below if you like.
Leave the second box empty and you get whatever opened or changed recently, closing soonest. Fill it in and it ranks against your words instead: that is the difference between a list and a shortlist.
Scientific Network Management will send you the current list for these terms, and after that only what changes: a call that opens, a deadline that shifts, a clause that rules you out. Nothing is sent when nothing has moved. One click to stop, in every message.
One confirmation email and nothing else until you click it. No tracking pixels, no sharing, one click to unsubscribe.
Of every 100 Horizon Europe proposals
A funding strategy reads your institution's own published record against the calls that are open, and says in writing which are worth the year and which to decline, with the reason for each.
Scientific Network Management, the grant-writing practice behind this radar: 13 years of EU-funded research projects, and a founder who has served as Key Expert and Team Leader on two EU-funded technical assistance contracts establishing biotechnology centres in Türkiye.
SNM also does
No obligation, and nothing here is conditional on using us: searching the calls stays free and asks for nothing either way.